Simplex Trading’s Kindred Biosciences, Inc. KIN Stock Holding History

Simplex Trading’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-34,800	Closed	-$1K	–	12020
2021 Q3	$1K	Hold	34,800	–	–	﹤0.01%	9733
2021 Q2	$319K	Buy	34,800 +34,428	+9,255%	+$200K	﹤0.01%	4877
2021 Q1	$184K	Buy	372 +178	+92%	+$860	﹤0.01%	4875
2020 Q4	$83K	Buy	+194	New	+$789	﹤0.01%	5640

Simplex Trading's KIN Position: Q1 2021 in Review

Simplex Trading sold out of Kindred Biosciences, Inc. (KIN) in Q1 2021, closing a stake of 10,979 shares — an estimated $53K sold.

Simplex Trading first reported a position in KIN in Q2 2015 and held it in 5 quarters. The position peaked at $47K in Q4 2020. 84 funds tracked by Wall St. Rank hold KIN as of Q1 2021.

Simplex Trading reported no remaining Kindred Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
Simplex Trading sold 10,979 Kindred Biosciences, Inc. shares in Q1 2021, an estimated $53K.
Simplex Trading first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 5 quarters.
Simplex Trading's Kindred Biosciences, Inc. position peaked at $47K in Q4 2020.
84 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.